Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Morreau

Showing results (201-210 of 257) with videos related to

Pageof 26
Sort By:
European Journal of Endocrinology|April 16, 2013
Mutational analyses of epidermal growth factor receptor and downstream pathways in adrenocortical carcinomaIlse G C Hermsen, Harm R Haak, Ronald R de Krijger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancerRamon Salazar, Paul Roepman, Gabriel Capella, et al.
The Journal of Clinical Endocrinology and Metabolism|November 12, 2014
Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasionWillie Yu, John R McPherson, Mark Stevenson, et al.
British Journal of Cancer|October 27, 2021
Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4Sarah Ouahoud, Rutger J Jacobs, Ludmilla L Kodach, et al.
The Oncologist|March 31, 2010
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discoverySabine Tejpar, Monica Bertagnolli, Fred Bosman, et al.
Gastroenterology|February 14, 2006
Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome)Yvonne M C Hendriks, Shantie Jagmohan-Changur, Heleen M van der Klift, et al.
Familial Cancer|May 23, 2019
Targeted next generation sequencing screening of Lynch syndrome in Tunisian populationRihab Ben Sghaier, Anne Maria Lucia Jansen, Ahlem Bdioui, et al.
JAMA Internal Medicine|April 2, 2014
Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancerMarlies S Reimers, Esther Bastiaannet, Ruth E Langley, et al.
Familial Cancer|January 22, 2015
High-resolution melting (HRM) re-analysis of a polyposis patients cohort reveals previously undetected heterozygous and mosaic APC gene mutationsAstrid A Out, Ivonne J H M van Minderhout, Nienke van der Stoep, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 12, 2018
High Growth Rate of Pancreatic Ductal Adenocarcinoma in <i>CDKN2A-p16-Leiden</i> Mutation CarriersIsaura S Ibrahim, Martin N Wasser, Yinghui Wu, et al.
Pageof 26

Showing results (201-210 of 257) with videos related to

Sort By:
Pageof 26
European Journal of Endocrinology|April 16, 2013
Mutational analyses of epidermal growth factor receptor and downstream pathways in adrenocortical carcinomaIlse G C Hermsen, Harm R Haak, Ronald R de Krijger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancerRamon Salazar, Paul Roepman, Gabriel Capella, et al.
The Journal of Clinical Endocrinology and Metabolism|November 12, 2014
Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasionWillie Yu, John R McPherson, Mark Stevenson, et al.
British Journal of Cancer|October 27, 2021
Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4Sarah Ouahoud, Rutger J Jacobs, Ludmilla L Kodach, et al.
The Oncologist|March 31, 2010
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discoverySabine Tejpar, Monica Bertagnolli, Fred Bosman, et al.
Gastroenterology|February 14, 2006
Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome)Yvonne M C Hendriks, Shantie Jagmohan-Changur, Heleen M van der Klift, et al.
Familial Cancer|May 23, 2019
Targeted next generation sequencing screening of Lynch syndrome in Tunisian populationRihab Ben Sghaier, Anne Maria Lucia Jansen, Ahlem Bdioui, et al.
JAMA Internal Medicine|April 2, 2014
Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancerMarlies S Reimers, Esther Bastiaannet, Ruth E Langley, et al.
Familial Cancer|January 22, 2015
High-resolution melting (HRM) re-analysis of a polyposis patients cohort reveals previously undetected heterozygous and mosaic APC gene mutationsAstrid A Out, Ivonne J H M van Minderhout, Nienke van der Stoep, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 12, 2018
High Growth Rate of Pancreatic Ductal Adenocarcinoma in <i>CDKN2A-p16-Leiden</i> Mutation CarriersIsaura S Ibrahim, Martin N Wasser, Yinghui Wu, et al.
Pageof 26